17 Rho-Associated Protein Kinase Inhibitors and Primary Open-Angle Glaucoma Pratap Challa, MD, MS and John J. Arnold, PhD Rho-associated protein kinase (ROCK) inhibitors have been broadly investigated over the past…
77 The FDA’s Role in the Regulation of New Diagnostic and Surgical Devices Julie Kim, MD; Tieuvi Nguyen, PhD; and Malvina Eydelman, MD In the United States, a device is…
76 Adherence to Glaucoma Medical Therapy Lisa S. Gamell, MD; Norberto Mancera, MD; and Gretta Fridman, MD One of the great clinical challenges in the management of glaucoma is getting…
40 Glaucoma in the Pseudophakic and Aphakic Eye Ian Conner, MD, PhD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM A revolution has occurred in cataract surgery…
51 Juvenile Open-Angle Glaucoma Janey L. Wiggs, MD, PhD Primary open-angle glaucoma (POAG) that develops in patients younger than 40 years of age has been called juvenile-onset POAG (JOAG) or…
26 Angle-Closure Glaucoma Evaluation and Treatment After Iridotomy Mina Pantcheva, MD; Malik Y. Kahook, MD; and David L. Epstein, MD, MMM ROUTINE FOR EVALUATION OF PATIENT AFTER LASER IRIDOTOMY The…
37 Angle-Closure Glaucoma Secondary to Acute Myopia Malik Y. Kahook, MD and David L. Epstein, MD, MMM Angle-closure glaucoma secondary to acute myopia is a relatively rare condition that an…
21 Pseudoexfoliation Syndrome and Open-Angle Glaucoma Pratap Challa, MD, MS and David L. Epstein, MD, MMM Once thought to be an unusual form of open-angle glaucoma primarily associated with Scandinavian…
47 Glaucoma Associated With Extraocular Venous Congestion (Increased Episcleral Venous Pressure) Ian Conner, MD, PhD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM Increased episcleral venous pressure…
46 Hemolytic or Ghost-Cell Glaucoma David L. Epstein, MD, MMM CLINICAL FINDINGS The term hemolytic glaucoma was introduced by Fenton and Zimmerman1 to describe the clinical and histologic findings in…
